Studies have shown that overexpressing TMEM147 in hepatocellular carcinoma upregulates GPX4 activity by promoting DHCR7 expression, leading to tumor cell ferroptosis resistance and increased lipid metabolism in macrophages, thereby promoting their M2 polarization and exerting immunosuppressive effects [140]. The gene discussed is GPX4; the disease is neoplasm.